Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in Atopic Dermatitis
NCT00822783Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2001
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in atopic dermatitis (AD), sponsored by Medical University of Vienna. Started Oct 2001; status: completed.
02
Drugs
omalizumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00822783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822783.